Works matching IS 15747891 AND DT 2018 AND VI 12 AND IP 7
Results: 15
Matrine suppresses KRAS‐driven pancreatic cancer growth by inhibiting autophagy‐mediated energy metabolism.
- Published in:
- Molecular Oncology, 2018, v. 12, n. 7, p. 1203, doi. 10.1002/1878-0261.12324
- By:
- Publication type:
- Article
Targeting TWIST1 through loss of function inhibits tumorigenicity of human glioblastoma.
- Published in:
- Molecular Oncology, 2018, v. 12, n. 7, p. 1188, doi. 10.1002/1878-0261.12320
- By:
- Publication type:
- Article
Liver regeneration accelerates hepatitis B virus‐related tumorigenesis of hepatocellular carcinoma.
- Published in:
- Molecular Oncology, 2018, v. 12, n. 7, p. 1175, doi. 10.1002/1878-0261.12318
- By:
- Publication type:
- Article
Genomewide binding of transcription factor Snail1 in triple‐negative breast cancer cells.
- Published in:
- Molecular Oncology, 2018, v. 12, n. 7, p. 1153, doi. 10.1002/1878-0261.12317
- By:
- Publication type:
- Article
Exogenous IL‐6 induces mRNA splice variant MBD2_v2 to promote stemness in TP53 wild‐type, African American PCa cells.
- Published in:
- Molecular Oncology, 2018, v. 12, n. 7, p. 1138, doi. 10.1002/1878-0261.12316
- By:
- Publication type:
- Article
A novel RNA sequencing‐based miRNA signature predicts with recurrence and outcome of hepatocellular carcinoma.
- Published in:
- Molecular Oncology, 2018, v. 12, n. 7, p. 1125, doi. 10.1002/1878-0261.12315
- By:
- Publication type:
- Article
Induced PTF1a expression in pancreatic ductal adenocarcinoma cells activates acinar gene networks, reduces tumorigenic properties, and sensitizes cells to gemcitabine treatment.
- Published in:
- Molecular Oncology, 2018, v. 12, n. 7, p. 1104, doi. 10.1002/1878-0261.12314
- By:
- Publication type:
- Article
Selective induction of cancer cell death by VDAC1‐based peptides and their potential use in cancer therapy.
- Published in:
- Molecular Oncology, 2018, v. 12, n. 7, p. 1077, doi. 10.1002/1878-0261.12313
- By:
- Publication type:
- Article
The immunoglobulin‐like domain of neuregulins potentiates ErbB3/HER3 activation and cellular proliferation.
- Published in:
- Molecular Oncology, 2018, v. 12, n. 7, p. 1061, doi. 10.1002/1878-0261.12310
- By:
- Publication type:
- Article
Specific breast cancer prognosis‐subtype distinctions based on DNA methylation patterns.
- Published in:
- Molecular Oncology, 2018, v. 12, n. 7, p. 1047, doi. 10.1002/1878-0261.12309
- By:
- Publication type:
- Article
SALL2 represses cyclins D1 and E1 expression and restrains G1/S cell cycle transition and cancer‐related phenotypes.
- Published in:
- Molecular Oncology, 2018, v. 12, n. 7, p. 1026, doi. 10.1002/1878-0261.12308
- By:
- Publication type:
- Article
Vav1 downmodulates Akt in different breast cancer subtypes: a new promising chance to improve breast cancer outcome.
- Published in:
- Molecular Oncology, 2018, v. 12, n. 7, p. 1012, doi. 10.1002/1878-0261.12203
- By:
- Publication type:
- Article
Microfluidic enrichment of plasma cells improves treatment of multiple myeloma.
- Published in:
- Molecular Oncology, 2018, v. 12, n. 7, p. 1004, doi. 10.1002/1878-0261.12201
- By:
- Publication type:
- Article
FGFR2 amplification is predictive of sensitivity to regorafenib in gastric and colorectal cancers in vitro.
- Published in:
- Molecular Oncology, 2018, v. 12, n. 7, p. 993, doi. 10.1002/1878-0261.12194
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Molecular Oncology, 2018, v. 12, n. 7, p. 991, doi. 10.1002/1878-0261.12126
- Publication type:
- Article